Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -300.00% |
| Q2 2025 | 290.48% |
| Q1 2025 | -175.00% |
| Q4 2024 | -60.00% |
| Q3 2024 | 94.44% |
| Q2 2024 | 17900.00% |
| Q1 2024 | -90.70% |
| Q4 2023 | 107.41% |
| Q3 2023 | -1350.00% |
| Q2 2023 | -106.45% |
| Q1 2023 | -34.04% |
| Q4 2022 | 1466.67% |
| Q3 2022 | -80.00% |
| Q2 2022 | -68.75% |
| Q1 2022 | 860.00% |
| Q4 2021 | -87.80% |
| Q3 2021 | -8.89% |
| Q2 2021 | 309.09% |
| Q1 2021 | -81.03% |
| Q4 2020 | -23.68% |
| Q3 2020 | 15.15% |
| Q2 2020 | 60.98% |
| Q1 2020 | -34.92% |
| Q4 2019 | 14.55% |
| Q3 2019 | -11.29% |
| Q2 2019 | 77.14% |
| Q1 2019 | -30.00% |
| Q4 2018 | -7.41% |
| Q3 2018 | -8.47% |
| Q2 2018 | 15.69% |
| Q1 2018 | 88.89% |
| Q4 2017 | -12.90% |
| Q3 2017 | -8.82% |
| Q2 2017 | 61.90% |
| Q1 2017 | -27.59% |
| Q4 2016 | -76.80% |
| Q3 2016 | 525.00% |
| Q2 2016 | 100.00% |
| Q1 2016 | -28.57% |
| Q4 2015 | 75.00% |